Thorac Cardiovasc Surg 2015; 63 - OP97
DOI: 10.1055/s-0035-1544349

Further Insights in Acute Kidney Injury after Transcatheter Aortic Valve Implantation: Time of Onset of Kidney Injury is Crucial for Severity and Mortality Risk

M. Scherner 1, S. Ney 1, N. Madershahian 1, K. Kuhr 2, E. Kuhn 1, T. Rudolph 1, I. Slottosch 1, J. Wippermann 1, S. Baldus 1, T. Wahlers 1
  • 1Universitätsklinik Köln, Köln, Germany
  • 2Institut für medizinische Informatik und Statistik, Köln, Germany

Objective: Acute kidney Injury (AKI) is a frequent complication after transcatheter aortic valve implantation (TAVI) affecting outcome and mortality. The Valve academic research consortium adjusted the VARC II criteria now recommending a postoperative observation period of 7 days for Acute kidney injury (AKI) (VARC I: 72 hours). However, little is known about potential differences concerning the timing of the occurence of AKI after TAVI and whether this fact takes influence on the outcome.

Methods: Data of 436 patients after TAVI at our institution were analyzed according to VARC II criteria to gain further insight into 1) the incidence and severity (stages) of early- AKI (EAKI) (onset < 72 hours after TAVI) and late-AKI (LAKI) (>72 hour), 2) the impact of EAKI and LAKI on mortality and 3) to identify risk factors for the occurence of E- or LAKI.

Results: 36.3% developed postoperative AKI with a higher incidence of EAKI (66.7% versus LAKI 32.3%). Severe AKI (stages II + III) occurred more frequently in EAKI patients (31.3% vs 7.8% lAKI, p = 0.001). 30-day overall mortality was 8.2% with a mortality of 15.2% in EAKI-patients versus 0% in LAKI patients resulting in a 4.57 fold increased mortality risk after EAKI (95%CI 1.98–10.56; p < 0.001). LAKI did not influence early mortality. Kaplan Meier analysis revealed a significant impact of EAKI (p = 0.016) on one- and three-year survival, wheras LAKI did not affect mid-term survival (p = 0.269). Multivariate analyisis identified serum-creatiine > 1.1 mg/dl as independent predictor for E- and LAKI (EAKI:OR 4.67 95%CI 2.53–8.64 p < 0.001 + LAKI: OR 3.27 95%CI 1.60–6.68 p = 0.001). Additionally, contrast administration (> 135 ml/procedure) (OR 2.71 95%CI 1.22–6.02; p = 0.014) and diabetes (OR 1.4 95%CI 1.05–1.89; p = 0.023) were associated with EAKI.

Conclusion: AKI occurring within 72 hours postopertiely significantly affects short and midterm survival, in contrast to a later onset. Our clinical data suggest different pathophysiological mechanisms for the occurrence of E- or LAKI. Furher inverstigation is needed to completey understand the mechanisms of AKI after TAVI and to develop preventive strategies.